• Consumer Preferences and Willingness to Pay for Nutraceuticals: A Discrete Choice Experiment [Editor's Choice]

    May 1, 2021, 00:00

  • Mapping Utility Scores From the HeartQoL Questionnaire Into the EQ-5D for Ischemic Heart Disease

    May 1, 2021, 00:00

  • Patient Journey and Disease-Related Burden in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension: A Mixed Methods Study [Editor's Choice]

    May 1, 2021, 00:00

  • A Study Comparing Cost-Effectiveness of Combination Therapy for Preventing Opportunistic Infections Among Human Immunodeficiency Virus–Infected Adults on Antiretroviral Therapy

    May 1, 2021, 00:00

  • Similarities and Differences in Health-Related Quality-of-Life Concepts Between the East and the West: A Qualitative Analysis of the Content of Health-Related Quality-of-Life Measures

    May 1, 2021, 00:00

  • Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome

    May 1, 2021, 00:00

  • Current Development and Practice of Pharmacoeconomic Evaluation Guidelines for Universal Health Coverage in China

    May 1, 2021, 00:00

  • Is It Worth Delaying Total Knee Replacement as Late as Possible? A Cost-Effectiveness Analysis Using a Markov Model in the Indian Setting

    May 1, 2021, 00:00

  • Current Status of Research on the Mapping Function of Health Utility Values in the Asia Pacific Region: A Systematic Review [Editor's Choice]

    May 1, 2021, 00:00

  • Editorial Board

    May 1, 2021, 00:00

  • Cost-Effectiveness of Lenvatinib in the Treatment of Patients With Unresectable Hepatocellular Carcinomas in Japan: An Analysis Using Data From Japanese Patients in the REFLECT Trial

    May 1, 2021, 00:00

  • Coronavirus Disease 2019 in 5 Neighboring Limited-Resource Countries: A Financial and Health Threat

    May 1, 2021, 00:00

  • Facing the Threat of COVID-19 in Pakistan: A Nation’s Dilemma

    May 1, 2021, 00:00

  • Predictors of Health-Related Quality-of-Life Status Among Elderly Patients With Cardiovascular Diseases

    May 1, 2021, 00:00

  • Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country

    May 1, 2021, 00:00

  • Validity of the Malay EQ-5D-3L in the Malaysian Transfusion-Dependent Thalassemia Population

    May 1, 2021, 00:00

  • Health-Related Quality of Life Among Children With Pneumonia in Indonesia Using the EuroQoL Descriptive System Value Set for Indonesia

    May 1, 2021, 00:00

  • Suggestions to Make Health Technology Assessment in India an Efficient Process

    May 1, 2021, 00:00

  • Cost-Effective Analysis of the Congenital Hypothyroidism Screening Program in Sri Lanka

    May 1, 2021, 00:00

  • Socioeconomic Impact of Hospitalization Expenditure for Treatment of Noncommunicable Diseases in India: A Repeated Cross-Sectional Analysis of National Sample Survey Data, 2004 to 2018

    May 1, 2021, 00:00

  • Economic Burden of Stroke in Iran: A Population-Based Study

    May 1, 2021, 00:00

  • A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infections in an Adult-Outpatient Setting in Japan

    May 1, 2021, 00:00

  • Economic Viability and Efficacy of Day Case Versus Inpatient Tonsillectomy in Southern Iran

    May 1, 2021, 00:00

  • Development and Validation of a Chronic Kidney Disease Prediction Model for Type 2 Diabetes Mellitus in Thailand

    May 1, 2021, 00:00

  • Reviewer Acknowledgment

    Dec 16, 2020, 17:31

  • Copyright/Subscription

    Dec 9, 2020, 11:53

  • Satisfaction With Healthcare Services Among Patients With Diabetes, Hypertension, and/or Dyslipidemia in Mexico: A Cross-Sectional Study

    Dec 1, 2020, 00:00

  • International Experience in Therapeutic Value and Value-Based Pricing: A Rapid Review of the Literature

    Dec 1, 2020, 00:00

  • Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia

    Dec 1, 2020, 00:00

  • Editorial Board

    Dec 1, 2020, 00:00

  • Is There Something Else Beyond Cost-Effectiveness Analysis for Public Health Decision Making?

    Dec 1, 2020, 00:00

  • Omitted Conflict of Interest Disclosures in Previously Published Articles

    Dec 1, 2020, 00:00

  • 24/7 Physical Therapy Intervention With Adult Patients in a Chilean Intensive Care Unit: A Cost-Benefit Analysis in a Developing Country

    Dec 1, 2020, 00:00

  • Limitations and Challenges of Conducting Budget Impact Analyses in Rare Diseases: A Case Study of Alpha-1 Antitrypsin Deficiency (Editor's Choice)

    Dec 1, 2020, 00:00

  • Cost-Effectiveness of the Addition of Bevacizumab to First-Line Chemotherapy With Carboplatin and Paclitaxel in Patients With Non–Small Cell Lung Cancer

    Dec 1, 2020, 00:00

  • Willingness of Infertile Couples to Pay for In Vitro Fertilization Treatment in the Integrated Human Reproduction Section of the Escola Paulista de Medicina, São Paulo Federal University

    Dec 1, 2020, 00:00

  • Cost Analysis of Cancer in Brazil: A Population-Based Study of Patients Treated by Public Health System From 2001-2015 (Editor's Choice)

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis and Budget Impact: Antimuscarinics and Mirabegron for the Treatment of Patients With Urge Urinary Incontinence: The Brazilian Public Health System Perspective

    Dec 1, 2020, 00:00

  • Costs Associated With Early Vascular and Biliary Complications in Liver-Transplanted Patients in a Hospital in Antioquia, Colombia 2019: A Case Series

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Point-of-Care Rapid Testing Versus Laboratory-Based Testing for Antenatal Screening of Syphilis in Brazil

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Rehabilitation Interventions for Teeth With Extensive Coronary Destruction

    Dec 1, 2020, 00:00

  • What Do Doctors Think About Value-Based Healthcare? A Survey of Practicing Physicians in a Private Healthcare Provider in Brazil (Editor's Choice)

    Dec 1, 2020, 00:00

  • Implementing Health Technology Assessments in Latin America: Looking at the Past, Mirroring the Future. A Perspective from the ISPOR Health Technology Assessment Roundtable in Latin America (Editor's Choice)

    Dec 1, 2020, 00:00

  • How Educational Inequalities in Cardiovascular Mortality Evolve While Healthcare Insurance Coverage Grows: Colombia, 1998 to 2015

    Dec 1, 2020, 00:00

  • Table of Contents

    Dec 1, 2020, 00:00

  • Treatment Satisfaction Questionnaire for Medication (TSQM version 1.4): Ceiling and Floor Effects, Reliability, and Known-Group Validity in Brazilian Outpatients With Hypertension

    Dec 1, 2020, 00:00

  • Multi-Criteria Model for Evaluating Drugs to Prevent Deep Venous Thrombosis Associated With Orthopedic Surgery: A Hospital-Based Case Study

    Dec 1, 2020, 00:00

  • Treatment With Liposomal Amphotericin B for All Confirmed Cases of Human Visceral Leishmaniasis in Brazil: A Budget Impact Analysis

    Dec 1, 2020, 00:00

  • Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data (Editor's Choice)

    Dec 1, 2020, 00:00

  • Adaptation and Validation of the Health Belief Model Scale for Breast Self-Examination in Mexican Women

    Dec 1, 2020, 00:00

  • Copyright/Subscription

    Sep 12, 2020, 10:30

  • PCN15 Disease Burden of Myelodysplastic Syndrome UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PGI7 Cost-Effectiveness Analysis of Vonoprazan Versus Proton Pump Inhibitors in the Treatment of Reflux Esophagitis in China

    Sep 1, 2020, 00:00

  • PCN27 Study of Initial Treatment Cost for ACUTE Leukemia Patients in Vietnam

    Sep 1, 2020, 00:00

  • PCN36 Cost-Effectiveness Analysis of Pembrolizumab Versus Nivolumab As the First-LINE Treatment for Advanced and Metastatic NON-SMALL CELL LUNG Cancer in Germany

    Sep 1, 2020, 00:00

  • PCN1 IMPACT of PD-1/PD-L1 Inhibitors on Health Outcomes for Patients with Cancer in South Korea

    Sep 1, 2020, 00:00

  • PND29 Children with Hyperactive-Impulsive Disorder Benefit from Yoga Exercises

    Sep 1, 2020, 00:00

  • PRO18 Incidence, Mortality, Hospitalizations, and Expenditures for Pemphigus in Taiwan

    Sep 1, 2020, 00:00

  • PSU8 Health Economic Evaluation of Protocol Change Including IV Iron Ferric Carboxymaltose Versus Control Group for HIP Surgery Patients with Iron Deficiency Anemia (IDA) in Korea

    Sep 1, 2020, 00:00

  • PDG16 Pharmaceutical Expenditure Monitoring for Price-Volume Negotiation in South Korea : Lessons and Improvement Points Learned over 11 YEARS

    Sep 1, 2020, 00:00

  • PMU1 Dancing with the Dragon: Considerations and Learnings in the 2019 China National Reimbursement Drug LIST Negotiations

    Sep 1, 2020, 00:00

  • PCN21 Disease Burden of Multiple Myeloma UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PRO5 IMPACT of Prophylaxis Costs in a Pediatric Patient Diagnosed with Severe Hemophilia a with Inhibitors in Guayaquil, Ecuador

    Sep 1, 2020, 00:00

  • PCV24 Health Technology Assessment Submissions for Cardiovascular Interventions in the ASIA-Pacific Region

    Sep 1, 2020, 00:00

  • PNS70 EQ-5D-5L in China and JAPAN: Population Norms and Comparison between the Countries

    Sep 1, 2020, 00:00

  • PNS59 Reliability and Validity of the SF-12V2 Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the U.S. Older Adult Population

    Sep 1, 2020, 00:00

  • PRS1 Comparison of Clinical Outcomes Associated with Different Inhaler Devices in Asthma and COPD

    Sep 1, 2020, 00:00

  • PMU9 Brand-Switching Behavior Following the Implementation of a 63% Tax Increase on Cigarettes in Taiwan

    Sep 1, 2020, 00:00

  • PCN49 Disease Burden of Classical Hodgkin Lymphoma UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMD10 Cost-Utility Analysis of Robotic-Assisted Surgery for Prostate Cancer Patients in JAPAN

    Sep 1, 2020, 00:00

  • PIN37 Projection of Covid-19 Based on Decision Tree Analysis: WE Have NOT Won but WE Have NOT Lost the WAR!

    Sep 1, 2020, 00:00

  • PMU21 Incorporating Preference Heterogeneity in Public Healthcare Policy Decision-Making: A Scoping Review of the Literature

    Sep 1, 2020, 00:00

  • Disclosure Information

    Sep 1, 2020, 00:00

  • PDB10 Cost-Effectiveness of Canagliflozin Versus Sitagliptin in Chinese Patients with Type 2 Diabetes on Background Metformin Monotherapy

    Sep 1, 2020, 00:00

  • PCV1 Cardiac Rehabilitation Program in a Tertiary Hospital in Peninsular Malaysia: Outcome and Associations

    Sep 1, 2020, 00:00

  • PND6 Drug Utilization of Gastrodin Injection on the Treatment of Dizziness and Vertigo: An Analysis Using Electronic Medical Records in China

    Sep 1, 2020, 00:00

  • PIN45 Comparison of Antibiotics Policies between European Union Countries and JAPAN

    Sep 1, 2020, 00:00

  • PMS18 Factors Influencing Length of STAY (LOS) and Real-World Discharge Readiness (DR) for TOTAL Knee Arthroplasty in Australia

    Sep 1, 2020, 00:00

  • PCV13 Health Economic Evaluation of Screening and Treating Children with Familial Hypercholesterolemia EARLY in Life: Many Happy Returns on Investment?

    Sep 1, 2020, 00:00

  • PNS16 Health and Economic Burden of Smoking in Indonesia

    Sep 1, 2020, 00:00

  • Table of Contents

    Sep 1, 2020, 00:00

  • PRS6 Economic Eligibility Assessment for Patient Assistance Program (PAP) Among Chronic Obstructive Pulmonary Disease (COPD) Patients in Urban China

    Sep 1, 2020, 00:00

  • Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland

    Sep 1, 2020, 00:00

  • PRS4 Modeling Economic and Health Burden of Chronic Obstructive Pulmonary Disease (COPD) in China over the Next 20 YEARS

    Sep 1, 2020, 00:00

  • PCN38 Cost-Effectiveness of Mammography As a Screening Test for EARLY Detection of Breast Cancer

    Sep 1, 2020, 00:00

  • PCN37 Cost-Effectiveness Analysis of Pembrolizumab Versus Nivolumab As the First-LINE Treatment for Advanced and Metastatic NON-SMALL CELL LUNG Cancer in France

    Sep 1, 2020, 00:00

  • PNS49 Building Capacity for HTA in the Philippines: An Imperative UNDER UHC

    Sep 1, 2020, 00:00

  • PRS15 Evaluating Disease and Economic Burden of Severe Asthma in India

    Sep 1, 2020, 00:00

  • PDG17 The Economic IMPACT Analysis of a Proposal to Abandon NON-Prescription Drug Reimbursement in Thailand, a Case Study of NON-Sedating Antihistamines

    Sep 1, 2020, 00:00

  • PIH15 NOVEL Target Identification and Drug Repurposing for Systemic Onset Juvenile Idiopathic Arthritis (SJIA): An Insilico Approach

    Sep 1, 2020, 00:00

  • PNS27 Diffusion of Pharmaceutical Innovations in the Public Healthcare Setting in Malaysia

    Sep 1, 2020, 00:00

  • Evaluation of Psychometric Quality of EQ-5D-5L Scale for Assessing Health-Related Quality of Life of Malaria Patients

    Sep 1, 2020, 00:00

  • PNS53 Differences in Evidence Reviews Requirements for Health Technology Assessment (HTA) Document Development between Selected Countries

    Sep 1, 2020, 00:00

  • PNS25 Applying Regulatory Science to Traditional Medicines for Improving Public Safety and Facilitating Innovation: Experiences in China

    Sep 1, 2020, 00:00

  • PMS6 Incidence and Prevalence of Osteoporosis and Related Fractures in ASIA and the Pacific: A Systematic Review

    Sep 1, 2020, 00:00

  • PRO3 Psoriasis As a PROXY for Health-Related Utility Values for Erythrodermic Cutaneous T-CELL Lymphoma

    Sep 1, 2020, 00:00

  • PMU8 The Increasing Burden of NON-Communicable Diseases in India

    Sep 1, 2020, 00:00

  • PSU14 Patient-Related Risk Factors for Periprosthetic Joint Infection and Postoperative Mortality Following TOTAL Knee Arthroplasty, a Nationwide Population-Based Study

    Sep 1, 2020, 00:00

  • PSS1 IMPACT of ITCH on SLEEP in Adults with Atopic Dermatitis: A Targeted Literature Review

    Sep 1, 2020, 00:00

  • PIH1 Development and Validation of a Prediction MODEL on Severe Maternal Outcomes Among Pregnant Women with PRE-Eclampsia: A 10-Year Cohort Study

    Sep 1, 2020, 00:00

  • PDB21 Safety and Efficacy Comparison between Insulin Degludec and Insulin Glargine

    Sep 1, 2020, 00:00

  • PIN30 Elements to Consider for a Comprehensive Assessment of the Public Health IMPACT of Vaccination

    Sep 1, 2020, 00:00

  • PND11 Pharmacoeconomic Evaluation of Multiple Sclerosis Therapy Costs in Central ASIA

    Sep 1, 2020, 00:00

  • PND23 Treatment Gaps in Deep Brain Stimulation for Patients with Parkinson's Disease: A Comparative Analysis of Nine High-Income Countries

    Sep 1, 2020, 00:00

  • PMD7 Analysis of Medical Device Recall Reports in China from a Regulatory Science Perspective: Implications for Post-Marketing Surveillance

    Sep 1, 2020, 00:00

  • PMU26 The Health-Related Quality of Life in Different Disease Population Based on EQ-5D-5L: A Systematic Review

    Sep 1, 2020, 00:00

  • PCN106 Treatment Patterns and Health Resource Utilization in Patients with Hepatocellular Cancer (HCC) Following Failure of Sorafenib in Real World Setting in Taiwan

    Sep 1, 2020, 00:00

  • PNS6 Risk Of Bias In Model-Based Economic Evaluations Of Tobacco Control Interventions In Asia: A Systematic Review

    Sep 1, 2020, 00:00

  • PNS42 Health Care Professionals and Mobile Applications: A Systematic Review

    Sep 1, 2020, 00:00

  • PDB7 Cost-Effectiveness Analysis of Once-Weekly Semaglutide As the Second-LINE Treatment for Type 2 Diabetes Mellitus Patients

    Sep 1, 2020, 00:00

  • PCV8 Cost-Utility and Budget IMPACT Analysis of Using Ranolazine in the Treatment of Refractory Stable Angina, an Iranian Heath System Perspective

    Sep 1, 2020, 00:00

  • PND13 Burden of Illness of Spinal Muscular Atrophy: An Update

    Sep 1, 2020, 00:00

  • PDB4 Study on Standard Criteria of SERUM Uric Acid and Factors of High Uric Acid in Children Using Claims Database in JAPAN

    Sep 1, 2020, 00:00

  • PCV19 Economic Burden of Disease on Patients with ACUTE Myocardial Infarction Combining Dyslipidemia in China

    Sep 1, 2020, 00:00

  • PDB8 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Insulin Degludec in Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PCN76 Analysis of the Status of the MULTI-Indications for Anticancer Drugs and Their Price Reduction in South Korea

    Sep 1, 2020, 00:00

  • PNS20 Repercussions of Physical Exercises on Physical Health

    Sep 1, 2020, 00:00

  • PCN54 Drug Selection for Formulary Inclusion: An Exploratory Case Study of Oncology Medicines in Jordan

    Sep 1, 2020, 00:00

  • PNS18 UNDER Threat of Covid-19, Is IT Against Humanitarianism to Adopt Sealed Management in Public Health Emergencies? a Survey Based on Chinese Public Attitudes Towards the Lockdown of Wuhan, China

    Sep 1, 2020, 00:00

  • PIN53 The Usability Testing of the Integrated E-Healthcare Services (IEHS) Web-Based Application in the Therapy Management of HIV and Tuberculosis in Indonesia

    Sep 1, 2020, 00:00

  • PMU28 Utilization Patterns of a Japanese Biomedical Database, Ichushi, in Real-World Evidence Review: A Scoping Review

    Sep 1, 2020, 00:00

  • PNS34 IMPACT of Drug Price Formation Mechanism on Medicine Availability: Evidence from China

    Sep 1, 2020, 00:00

  • PCN98 Assessment of Quality of Life in Patients with Metastatic Breast Cancer and Its Pharmaceutical Management in Tertiary Care Hospital: A Prospective Observational Study

    Sep 1, 2020, 00:00

  • PCN59 A Systematic Review of Prognostic Factor That IMPACT on Overall Survival and Proression-Free Survival in Triple-Negative Breast Cancer (TNBC)

    Sep 1, 2020, 00:00

  • PNS58 The Efficiency Analysis of 19 Medical Centers in Taiwan

    Sep 1, 2020, 00:00

  • PND5 Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in the United States

    Sep 1, 2020, 00:00

  • PNS60 Use of Artificial Intelligence with Distillersr Software in Selected Systematic Literature Reviews

    Sep 1, 2020, 00:00

  • PMU12 How Are Quarantine Impacting on the Health-Related Quality of Life?

    Sep 1, 2020, 00:00

  • PDG15 Dollars DRIVE Decisions: TOTAL Healthcare Spending Best Predicts Country Selection for New Drug Launches

    Sep 1, 2020, 00:00

  • PMU25 Measuring Medication Adheren Application of Group-Based Trajectory MODEL for Australians with Chronic Health Conditions Requiring Continuous Use of Medication

    Sep 1, 2020, 00:00

  • PIN34 Effects of Meteorological Factors on the Daily Domestic New CASES of Coronavirus Disease (COVID-19) in Asian Countries: A MULTI-Country Generalized Additive Modeling Analysis

    Sep 1, 2020, 00:00

  • PDG7 Cost Minimization Analysis of Dexamethasone Intravitreal Implant and Ranibizumab for Rvo-Macular Edema in China

    Sep 1, 2020, 00:00

  • PNS17 Experience and Prevalence of Iqos Heated Tobacco Product Among Adolescents in Taiwan

    Sep 1, 2020, 00:00

  • PCN57 Frequency of Myalgia in Patients Receiving Platinum Chemotherapy

    Sep 1, 2020, 00:00

  • PCN44 Disease Burden of Follicular Lymphoma UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PNS41 Preferences of Older Patients with Chronic Diseases for Medication Review Services in Shanxi, China: Results from a Discrete Choice Experiment

    Sep 1, 2020, 00:00

  • PNS1 Real-World DATA Collection in China: Challenges and Recommendations to Ensure DATA Quality

    Sep 1, 2020, 00:00

  • PDG20 Availability and Affordability of Oncologic Immunotherapies across Multiple-Countries

    Sep 1, 2020, 00:00

  • PMU20 Is There an Implicit Willingness-to-Pay Threshold in Singapore?

    Sep 1, 2020, 00:00

  • PIH10 Estimating Economic Burden of CHILD Asthma Attributing to Exposure to PM2.5 in JAPAN

    Sep 1, 2020, 00:00

  • PND30 Breathing Training HAS Positive Effect on Attention in Children with ADHD

    Sep 1, 2020, 00:00

  • PCN108 Economic Burden in Patients with Prostate Cancer: Using HIRA NPS-2016 Database

    Sep 1, 2020, 00:00

  • PCN29 Diagnosing and Classifying ACUTE Leukemia Patients through Immunophenotyping By FLOW Cytometry in Indonesia

    Sep 1, 2020, 00:00

  • PRS18 The IMPACT of Idiopathic Pulmonary Fibrosis on Health State Utility Values: Evidence from Australia

    Sep 1, 2020, 00:00

  • PCV7 Budget IMPACT Analysis on Fufang Xueshuantong Capsule in Treating Stable Angina Pectoris in China

    Sep 1, 2020, 00:00

  • PNS22 Hospital Ownership and National Essential Medicines Policy: A Comparative Study between the Public and Private Primary Health-Care Institutions in Nantong, China

    Sep 1, 2020, 00:00

  • PCV2 Volatile Anesthetics Versus TOTAL Intravenous Anesthesia in Patients Undergoing Coronary Artery Bypass Grafting: An Updated Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PDG21 Risk-Sharing Agreements: Experience That China Could Learn from European and Other EAST-Asian Countries

    Sep 1, 2020, 00:00

  • PSU3 Clinical Outcomes and Economics Associated with Surgical Aortic Valve Replacement in Taiwan

    Sep 1, 2020, 00:00

  • PCN52 Disease Burden of Prostate Cancer UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PBI8 The Burden of Health Care Costs for Psoriasis Patients Treated with Biologics in South Korea

    Sep 1, 2020, 00:00

  • PRS17 Barriers to and Competency with the Use of Metered Dose Inhaler and Its IMPACT on Disease Control Among Adult Asthmatic Patients in Ethiopia

    Sep 1, 2020, 00:00

  • Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema

    Sep 1, 2020, 00:00

  • PRO13 In-Silico Determination of Therapeutic Possibilities for Type-1 Gaucher Disease: A GENE Database Linked Analysis

    Sep 1, 2020, 00:00

  • PCN26 Disease Burden of ACUTE Myelogenous Leukemia UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PRS11 Comparison of Health-Related Quality of Life for Adult Patients with Asthma in ASIA and the U.S

    Sep 1, 2020, 00:00

  • PNS62 An Expert Survey on Talent Cultivation in Health Technology Assessment

    Sep 1, 2020, 00:00

  • PCN48 Cost-Effectiveness Analysis of Pertuzumab with Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Neoadjuvant Treatment of HER2-Positive EARLY or Locally Advanced Breast Cancer: Update Results after National ...

    Sep 1, 2020, 00:00

  • PIH18 Characterizing the IMPACT of PDE5I Use on the Health and Economic Burden of Erectile Dysfunction in the US, JAPAN, and China

    Sep 1, 2020, 00:00

  • PRS19 Use of Patient Reported Outcomes in Asthma Product Development in JAPAN: A Review of Labeled Products

    Sep 1, 2020, 00:00

  • PMS11 Pharmaco-Economic Study of Intra-Artcular Hyaloronic Acid VS Intra- Articular Corticosteroid in Egyptian Patients Receiving Standard Care Therapy from the Patient Perspective

    Sep 1, 2020, 00:00

  • PIN29 Evaluation of Healthcare Workers' Knowledge, Attitude and Practices Related to Covid-19: A Multicenter CROSS-Sectional Study from Pakistan

    Sep 1, 2020, 00:00

  • PMU3 Medical Cost for Children with Infantile Hemangiomas in Southern China: Investigation Based on Medical Record DATA

    Sep 1, 2020, 00:00

  • PCN40 Cost-Utility Analysis of Pembrolizumab Versus Platinum Based Chemotherapy As the First-LINE Treatment for Advanced and Metastatic NON-SMALL CELL LUNG Cancer (NSCLC) in UK

    Sep 1, 2020, 00:00

  • PND18 The Impact Of Anxiety Caused By Pharmacy Licence Examination Core Competency Of Fourth Year Pharmacy Students Of Burapha University 2018

    Sep 1, 2020, 00:00

  • PCN104 Treatment Patterns and Health Resource Utilization in Patients with HR+/HER2- Locally Advanced or Metastatic Breast Cancer in Real World Setting in Taiwan

    Sep 1, 2020, 00:00

  • Productivity Loss in Patients With Chronic Diseases: A Pooled Economic Analysis of Hungarian Cost-of-Illness Studies [Editor's Choice]

    Sep 1, 2020, 00:00

  • PCN20 Comparison of Nab-paclitaxel PLUS Gemcitabine Versus FOLFIRINOX in First LINE Treatment of Metastatic Pancreatic Cancer in China: A Cost-Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PDB18 Frequency of Local Reactions of Insulin in Self-Injecting Diabetics

    Sep 1, 2020, 00:00

  • PAM4 Cost-Effectiveness of Dangguixu-SAN for Patients with Mild to Moderate Ankle Sprain

    Sep 1, 2020, 00:00

  • PDG2 Survey of Usage of Molecular Targeted Drugs in LUNG Cancer Based on Claims DATA in JAPAN

    Sep 1, 2020, 00:00

  • PSS4 Disease Burden of Rvo-ME in China – a Societal VALUE Perspective

    Sep 1, 2020, 00:00

  • PMD6 How to Promote the Application of Regulatory Science in Combination Products

    Sep 1, 2020, 00:00

  • PCN28 Cost-Effectiveness Analysis of Avelumab for Treatment-Experienced and Treatment-Naïve Patients with Metastatic Merkel CELL Carcinoma in Taiwan

    Sep 1, 2020, 00:00

  • PMH5 Assessing the IMPACT of New Policy for Patients with Mental Disorders on Cost of Drug Prescription: An Interrupted Time Series Analysis

    Sep 1, 2020, 00:00

  • PCN8 Real World Treatment Patterns, Healthcare Resource Utilization (HCRU), Economic Outcomes and Survival Associated with Esophageal Cancer in JAPAN

    Sep 1, 2020, 00:00

  • PMS12 The Health Economics Analyses of TOTAL Knee Arthroplasty: A Literature Review

    Sep 1, 2020, 00:00

  • PNS14 Investigation of Physicians’ Digital Activities on Mitigating the IMPACT of Covid-19 in China

    Sep 1, 2020, 00:00

  • PIN25 The IMPACT of Childhood Pneumococcal Conjugate Vaccine Immunisation on Pneumonia Admissions in Hong Kong: A Population-Based Interrupted Time Series Analysis from 2004-2017

    Sep 1, 2020, 00:00

  • PBI1 Comparison of the Combination of Recombinant Follicle-Stimulating Hormone and Recombinant Luteinizing Hormone Protocol Versus Human Menopausal Gonadotropin Protocol in Controlled Ovarian Stimulation: A Systematic Review and Meta-Analys ...

    Sep 1, 2020, 00:00

  • PSU5 Economic Evaluation of Endovscular Versus OPEN Repair for Ruptured Abdominal Aortic Aneurysm

    Sep 1, 2020, 00:00

  • PCN92 An Investigation of Estimation Efficiency of Area UNDER the Curve (AUC) Using Parametric Models

    Sep 1, 2020, 00:00

  • PNS69 Measuring and Valuing Patient Experience

    Sep 1, 2020, 00:00

  • PCN87 Key Clinical and Economic Rationales for Oncology Reviews in South Korea

    Sep 1, 2020, 00:00

  • PCV3 Global Landscape of Clinical Genomic Sequencing: Who, Where, and How?

    Sep 1, 2020, 00:00

  • PSY2 Evaluating Patient-Reported Outcomes and Work Productivity Among Patients with Psoriasis in Taiwan

    Sep 1, 2020, 00:00

  • Barriers to Diabetes Adherence: Translation and Cultural Adaptation of the Instrument Into Arabic Context [Editor's Choice]

    Sep 1, 2020, 00:00

  • PMU5 Costs and Health Outcomes of Korean Children Attributable to Secondhand Smoke Exposure at HOME: An Analysis By a Markov MODEL

    Sep 1, 2020, 00:00

  • PMU19 Access to Medication Information By Hospitalized Patients from Bedside Terminal

    Sep 1, 2020, 00:00

  • PNS23 Setting Health Priorities in Low-Income and Middle-Income Countries in the ASIA-Pacific Region: The Case of Papua New Guinea

    Sep 1, 2020, 00:00

  • PIN31 The Epidemiology and Cost of Dengue Disease in Thailand: A Systematic Literature Review

    Sep 1, 2020, 00:00

  • PSY1 Medication Trends and Medical Costs Among Patients with Rheumatoid Arthritis on Biologics Treatment in Taiwan: A 6-Year Cohort Study Using a National Claims Database

    Sep 1, 2020, 00:00

  • PNS19 Using EQ-5D to Measure Health Status in Chinese Populations during the Covid-19 Pandemic

    Sep 1, 2020, 00:00

  • PGI8 Facility Size-Based Diagnostic Patterns of the Crohn's Disease-Associated Perianal Fistula Using an Employer-Based Health Insurance Claims Database in JAPAN

    Sep 1, 2020, 00:00

  • PCV20 A Real-World Study of Patient Characteristics and Treatment Patterns for Atrial Fibrillation in China

    Sep 1, 2020, 00:00

  • PMD1 Effectiveness and Cost Analysis for Peripheral Inserted Central Catheter VS Central Venous Catheter in China

    Sep 1, 2020, 00:00

  • PRS20 Rates of COPD Diagnosis and Health Outcomes in at Risk Populations: An Insight to the Diagnosis of COPD

    Sep 1, 2020, 00:00

  • PNS15 Effects of Different Family Planning Policies on Cesarean Section Rates from 2009 to 2019: A Population-Based Registry in China

    Sep 1, 2020, 00:00

  • PMU11 Current Status of the Use of Prescription Opioids in Korean Elderly Patients: An Analysis of the Health Insurance Review and Assessment Service-Aged Patient Sample DATA

    Sep 1, 2020, 00:00

  • PMD11 Efficacy of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • 8
  • 9
  • 10
  • »